IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v5y2014i1d10.1038_ncomms5229.html
   My bibliography  Save this article

p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression

Author

Listed:
  • Yong Lu

    (Lerner Research Institute, Cleveland Clinic)

  • Mingjun Zhang

    (Lerner Research Institute, Cleveland Clinic)

  • Siqing Wang

    (Institute of Translational Medicine, The First Hospital, Jilin University)

  • Bangxing Hong

    (Lerner Research Institute, Cleveland Clinic)

  • Zhiqiang Wang

    (The University of Texas MD Anderson Cancer Center)

  • Haiyan Li

    (Lerner Research Institute, Cleveland Clinic)

  • Yuhuan Zheng

    (Lerner Research Institute, Cleveland Clinic)

  • Jing Yang

    (The University of Texas MD Anderson Cancer Center)

  • Richard E. Davis

    (The University of Texas MD Anderson Cancer Center)

  • Jianfei Qian

    (Lerner Research Institute, Cleveland Clinic)

  • Jian Hou

    (Chang Zheng Hospital, The Second Military University)

  • Qing Yi

    (Lerner Research Institute, Cleveland Clinic)

Abstract

Dendritic cell (DC)-based cancer immunotherapy is a promising method, but so far has demonstrated limited clinical benefits. Regulatory T cells (Tregs) represent a major obstacle to cancer immunotherapy approaches. Here we show that inhibiting p38 MAPK during DC differentiation enables DCs to activate tumour-specific effector T cells (Teff), inhibiting the conversion of Treg and compromising Treg inhibitory effects on Teff. Inhibition of p38 MAPK in DCs lowers expression of PPARγ, activating p50 and upregulating OX40L expression in DCs. OX40L/OX40 interactions between DCs and Teff and/or Treg are critical for priming effective and therapeutic antitumour responses. Similarly, p38 MAPK inhibition also augments the T-cell stimulatory capacity of human monocyte-derived DCs in the presence of Treg. These findings contribute to ongoing efforts to improve DC-based immunotherapy in human cancers.

Suggested Citation

  • Yong Lu & Mingjun Zhang & Siqing Wang & Bangxing Hong & Zhiqiang Wang & Haiyan Li & Yuhuan Zheng & Jing Yang & Richard E. Davis & Jianfei Qian & Jian Hou & Qing Yi, 2014. "p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression," Nature Communications, Nature, vol. 5(1), pages 1-14, September.
    • Handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5229
    DOI: 10.1038/ncomms5229
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms5229
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms5229?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5229. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.